Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c1019
Identifier NCT06353828
Trial Title Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: CBD, synthetic form|DRUG: Placebo
Participant Information
Sponsor CannaMore Biotechs
City Kfar Saba
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-03-01
Primary Completion Date 2024-04-01
Completion Date 2025-04-01